To keep this in context, you said "More and more,

To keep this in context, you said "More and more, courts are finding that emails are acceptable as signed documents, so if there is an email from NP telling them to submit an incomplete BLA because he needs to appease shareholders, well, he could very well be screwed (just as we are)."

There's a signed contract between CytoDyn and Amarex, so if an email can be considered to be a "signed document", and you "didn't say it could supersede a contract", then how can NP "very well be screwed"?

My comments are just my opinions and should NOT be taken as investment advice.